• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Vitamins and Dietary Supplements in the Czech Republic Product Image

Vitamins and Dietary Supplements in the Czech Republic

  • ID: 313087
  • June 2014
  • Region: Europe, Czech Republic
  • 37 Pages
  • Euromonitor International

FEATURED COMPANIES

  • Arzneimittel GmbH
  • Dr B Scheffler GmbH
  • Holding AG & Co
  • Leciva as
  • Ortis, Laboratoires
  • Queisser Pharma GmbH & Co
  • MORE

Vitamins and dietary supplements saw 3% current value sales growth in 2013 as rising consumer health awareness and a strengthened desire for disease prevention drove demand. At the same time, the VAT rate in the Czech Republic increased in January 2013 by one percentage point, from 14% in 2012 to 15% in 2013 and from 20% in 2012 to 21% in 2013 (the Czech Republic uses two VAT rates).

The Vitamins and Dietary Supplements in Czech Republic report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2009-2013, allowing you to identify the sectors driving growth. Forecasts to 2018 illustrate how the market is set to change.

Product coverage: Dietary Supplements, Paediatric Vitamins and Dietary Supplements, Tonics and Bottled Nutritive Drinks, Vitamins.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Vitamins and Dietary Supplements market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arzneimittel GmbH
  • Dr B Scheffler GmbH
  • Holding AG & Co
  • Leciva as
  • Ortis, Laboratoires
  • Queisser Pharma GmbH & Co
  • MORE

VITAMINS AND DIETARY SUPPLEMENTS IN THE CZECH REPUBLIC

June 2014

LIST OF CONTENTS AND TABLES

Headlines
Trends
Vitamins
Dietary Supplements
Competitive Landscape
Prospects
Category Data
Summary 1 Dietary Supplements: Brand Ranking by Positioning 2013
Summary 2 Multivitamins: Brand Ranking by Positioning 2013
Table 1 Sales of Vitamins and Dietary Supplements by Category: Value 2008-2013
Table 2 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2008-2013
Table 3 Sales of Multivitamins by Positioning: % Value 2008-2013
Table 4 Sales of Dietary Supplements by Positioning: % Value 2008-2013
Table 5 NBO Company Shares of Vitamins and Dietary Supplements: % Value 2009-2013
Table 6 LBN Brand Shares of Vitamins and Dietary Supplements: % Value 2010-2013
Table 7 LBN Brand Shares of Vitamins: % Value 2010-2013
Table 8 LBN Brand Shares of Dietary Supplements: % Value 2010-2013
Table 9 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2013-2018
Table 10 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2013-2018
Green Swan Pharmaceuticals Cr As in Consumer Health (czech Republic)
Strategic Direction
Key Facts
Summary 3 Green Swan Pharmaceuticals CR as: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 4 Green Swan Pharmaceuticals CR as: Competitive Position 2013
Profarma Produkt Sro in Consumer Health (czech Republic)
Strategic Direction
Key Facts
Summary 5 Profarma Produkt sro: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Profarma Produkt sro: Competitive Position 2013
Vitar Sro in Consumer Health (czech Republic)
Strategic Direction
Key Facts
Summary 7 Vitar sro: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Vitar sro: Competitive Position 2013
Walmark As in Consumer Health (czech Republic)
Strategic Direction
Key Facts
Summary 9 Walmark as: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Walmark as: Competitive Position 2013
Zentiva Ks in Consumer Health (czech Republic)
Strategic Direction
Key Facts
Summary 11 Zentiva ks: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Zentiva ks: Competitive Position 2013
Executive Summary
the Czech Consumer Health Market Records Slight Growth in 2013
the Vat Rate Rises in 2013, Pushing Average Unit Prices Upwards
the Industry Remains Very Competitive in 2013 With Stronger Emphasis on Price-competition
Chemists/pharmacies Continues To Dominate Consumer Health Distribution in 2013
Consumer Health Has A Good Growth Outlook Over the Forecast Period
Key Trends and Developments
Vat for Drugs and Foodstuff Increases in 2013, Pushing Retail Prices Upwards
Private Label Boosted by New Product Launches
E-prescriptions Might Be Mandatory From 2015
Medical Cannabis Is Available in Czech Pharmacies
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services: Value 2008-2013
Table 12 Life Expectancy at Birth 2008-2013
Market Data
Table 13 Sales of Consumer Health by Category: Value 2008-2013
Table 14 Sales of Consumer Health by Category: % Value Growth 2008-2013
Table 15 NBO Company Shares of Consumer Health: % Value 2009-2013
Table 16 LBN Brand Shares of Consumer Health: % Value 2010-2013
Table 17 Penetration of Private Label in Consumer Health by Category: % Value 2008-2013
Table 18 Distribution of Consumer Health by Format: % Value 2008-2013
Table 19 Distribution of Consumer Health by Format and Category: % Value 2013
Table 20 Forecast Sales of Consumer Health by Category: Value 2013-2018
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2013-2018
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 13 OTC: Switches 2011-2013
Definitions
Sources
Summary 14 Research Sources

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arzneimittel GmbH
  • Dr B Scheffler GmbH
  • Holding AG & Co
  • Leciva as
  • Ortis, Laboratoires
  • Queisser Pharma GmbH & Co
  • MORE

Extract:

OTC Healthcare growing beyond expectations

The sales of OTC healthcare registered sound growth in 2005. Faster growth in the OTC sector was due to a rise
in advertising and accordingly higher awareness of Czech consumers with regard to the benefits of various OTC
brands. Consumers continued their interest in self-medication and health-consciousness and this also contributed
to the sizeable growth of OTC healthcare.

Another factor that caused such development was the increasingly hectic lifestyle of Czech consumers. One
result of this is that more people refuse to spend time waiting to see a doctor, particularly with ailments that are
not severe. As a result consumer interest in self-medication grew considerably over the review period. Cheaper
brands produced locally were most popular among Czech consumers.

Note: Product cover images may vary from those shown

Walmark as
Zentiva as
Pharma Nord sro
Whitehall Laboratories Ltd
Naturprodukt spol sro
Vitar sro
Delpharmea as
Dr B Scheffler GmbH
Ivax Pharmaceuticals sro
Ferrosan Czech sro
GlaxoSmithKline sro
Plusssz Vitamin Kft
Pfanner sro
Novartis sro
Bristol-Myers Squibb spol sro
Laurens Spethmann
Holding AG & Co
Roche sro
Krka sro
Ortis, Laboratoires
Dolpes SA
Boehringer Ingelheim sro
Naturwaren Ohg Dr Peter Theiss
Mucos Pharma CZ
ASTA Medica
Arzneimittel GmbH
Dr Reckeweg & Co GmbH
Queisser Pharma GmbH & Co
Nature's Life
Kneipp-Werke Leusser &
Oberhäußer GmbH & Co KG
Dr Rentschler
Arzneimittel GmbH & Co KG
Green Swan
Pharmaceuticals CR as
Leciva as
Slovakofarma as
Ivax-CR as Galena
Pharmavit Kft

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos